CVS Health (CVS) Stock Forecast & Price Target

CVS Health logo
$80.83 +0.79 (+0.99%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$79.95 -0.88 (-1.09%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVS Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
2
Buy
23

Based on 25 Wall Street analysts who have issued ratings for CVS Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 25 analysts, 2 have given a hold rating, and 23 have given a buy rating for CVS.

Consensus Price Target

$107.33
32.79% Upside
According to the 25 analysts' twelve-month price targets for CVS Health, the average price target is $107.33. The highest price target for CVS is $118.00, while the lowest price target for CVS is $92.00. The average price target represents a forecasted upside of 32.79% from the current price of $80.83.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CVS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CVS Health and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVS Analyst Ratings Over Time

TypeCurrent Forecast
11/22/25 to 11/22/26
1 Month Ago
10/23/25 to 10/23/26
3 Months Ago
8/24/25 to 8/24/26
1 Year Ago
11/22/24 to 11/22/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
23 Buy rating(s)
20 Buy rating(s)
22 Buy rating(s)
20 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$107.33$107.80$107.17$89.41
Forecasted Upside32.79% Upside15.24% Upside13.93% Upside14.74% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CVS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CVS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CVS Health Stock vs. The Competition

TypeCVS HealthHealthcare CompaniesBroader Market
Consensus Rating Score
2.92
2.32
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside32.79% Upside121.33% Upside22.05% Upside
News Sentiment Rating
Positive News

See Recent CVS News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/16/2026
Ben Hendrix
Ben Hendrix
4 of 5 stars
Lower TargetOutperform$113.00 ➝ $108.00+19.84%
11/13/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
Jessica Tassan
Jessica Tassan
2 of 5 stars
Set Target$106.00+18.61%
11/13/2026
Lance Wilkes
Lance Wilkes
4 of 5 stars
Reiterated RatingOutperform
11/12/2026Lower TargetOverweight$123.00 ➝ $112.00+25.23%
11/9/2026 UpgradeHold (C+) ➝ Buy (B-)
11/6/2026Set Target$103.00+26.81%
11/5/2026Lower TargetBuy$118.00 ➝ $107.00+31.74%
11/5/2026Lower TargetOutperform$112.00 ➝ $104.00+29.38%
11/5/2026Lower TargetOverweight$108.00 ➝ $107.00+33.66%
11/4/2026Reiterated RatingBuy$103.00+28.91%
11/4/2026Reiterated RatingBuy
11/4/2026 Reiterated RatingOutperform
10/9/2026Reiterated RatingNeutral
9/9/2026 Set Target$112.00+18.06%
8/19/2026Boost TargetBuy$104.00 ➝ $114.00+19.92%
8/12/2026Boost TargetOverweight$111.00 ➝ $118.00+26.09%
8/6/2026Set Target$107.00+10.60%
7/14/2026Boost TargetBuy$108.00 ➝ $118.00+11.26%
7/6/2026 Reiterated RatingHold$103.00+0.72%
6/22/2026Boost TargetBuy$100.00 ➝ $110.00+7.54%
6/8/2026Boost TargetOutperform$110.00 ➝ $115.00+20.18%
6/4/2026Boost TargetOverweight$106.00 ➝ $111.00+21.17%
5/7/2026 Boost TargetBuy$80.00 ➝ $100.00+14.05%
5/7/2026 Boost TargetBuy$88.00 ➝ $92.00+4.93%
3/2/2026 Lower TargetOutperform$100.00 ➝ $97.00+20.86%
2/12/2026Boost TargetBuy$95.00 ➝ $97.00+23.39%
9/8/2025 DowngradeStrong-Buy ➝ Hold
7/16/2025 Lower TargetMarket Perform$78.00 ➝ $72.00+12.86%
1/30/2025 UpgradeHold ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:00 PM ET.


Should I Buy CVS Health Stock? CVS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, November 21, 2026. Please send any questions or comments about these CVS Health pros and cons to contact@marketbeat.com.

CVS Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CVS Health Co.:

  • CVS Health Co. recently beat earnings expectations, reporting $2.09 in earnings per share for the quarter compared to the consensus estimate of $1.65, while revenue of $108.40 billion exceeded the forecast of $104.72 billion, indicating strong operational performance and potential for continued value creation.
  • The company has announced a strategic plan to separate into two independent, publicly traded companies focused on healthcare services and retail pharmacy, which may allow investors to more clearly value the distinct business segments and potentially unlock hidden value in the stock.
  • CVS Health Co. offers a dividend yield of 3.00% with a payout ratio of 30.97%, providing a relatively stable income stream for investors, as the company recently paid a quarterly dividend of $0.6650 per share.
  • Analysts maintain a positive outlook on the stock, with a consensus rating of "Moderate Buy" and an average price target of $107.33, which suggests significant upside potential from the current stock price of $80.83.
  • Recent insider activity shows confidence in the company, as Executive Vice President Prem Shah purchased 23,855 shares at an average price of $83.89, representing a 36.89% increase in their personal ownership of the stock.

CVS Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CVS Health Co. for these reasons:

  • The stock is currently trading at $80.83, which is significantly below its 50-day moving average of $88.42 and 200-day moving average of $89.29, suggesting that the stock is in a technical downtrend and may face further downward pressure.
  • Political uncertainty surrounding the "Medicare for All" initiative is weighing on health insurer stocks, creating sector-wide risk for CVS Health Co. and its Aetna business, as major changes to private insurance could disrupt the company's revenue streams.
  • Large institutional investors are reducing their exposure to the stock, with State Street Corp lessening its stake by 19.8% in the third quarter and selling 14,839,794 shares, which may indicate a lack of confidence among major market participants.
  • The company's balance sheet shows a debt-to-equity ratio of 0.71 and a current ratio of 0.85, indicating that CVS Health Co. has more short-term liabilities than assets and relies on debt financing, which could be a concern in a rising interest rate environment.
  • Despite the earnings beat, the stock experienced a sharp decline following the announcement of the company's breakup plan, suggesting that the market may be skeptical about the execution of the strategic separation and its impact on shareholder value.

CVS Forecast - Frequently Asked Questions

According to the research reports of 25 Wall Street equities research analysts, the average twelve-month stock price forecast for CVS Health is $107.33, with a high forecast of $118.00 and a low forecast of $92.00.

25 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last twelve months. There are currently 2 hold ratings and 23 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CVS shares.

According to analysts, CVS Health's stock has a predicted upside of 32.79% based on their 12-month stock forecasts.

Over the previous 90 days, CVS Health's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like CVS Health more than other "healthcare" companies. The consensus rating for CVS Health is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how CVS compares to other companies.


MarketBeat monitors more than a dozen sources for CVS Health analyst ratings, with the most recent rating issued on 11/16/2026.
From Our Partners